Program Type
Disease
Project Status

Displaying 1 - 16 of 16

The ACTIV Tracking Resistance and Coronavirus Evolution (TRACE) Working Group
The Problem Mutations in SARS-CoV-2 are occurring, and some that are reaching high frequency could reduce therapeutic or vaccine efficacy. ...
The Dr. Franklin A. Neva Memorial Fund
Overview The Dr. Franklin A. Neva Memorial Fund honors the legacy of Franklin A. Neva, M.D., a renowned virologist, parasitologist, clinici...
The Pew Scholars and Fellows Program in the Biomedical Sciences
Overview The Pew Biomedical Scholars Program provides funding to young investigators of outstanding promise in science relevant to the adva...
Understanding the Mechanisms of Intravenous BCG-Induced Protection Against Tuberculosis in Nonhuman Primates (TB Vaccine)
The Problem Only one vaccine (the BCG vaccine) protects infants against tuberculosis (TB) – the deadliest infection in the world – but ...
PAN-TB, Project to Accelerate New Treatments for Tuberculosis
The Problem The current treatment regimen for the most common form of tuberculosis (TB) requires taking multiple drugs for about six months...
PredictTB
Problem/ Solution The Problem Although standard-of-care therapies exist to treat tuberculosis (TB), patients w...
Roth Fellowship for CAEBV-HV Research
Overview The Roth Fellowship for CAEBV-HV Research was established in 2014 to support a two-year fellowship in the laboratory of Jeffrey I....
HIV Vaccine Development Using Virus-Like Particles
The Problem The number of HIV infections increases by nearly 2 million every year. Despite decades of Research, a safe and effective HIV va...
HIV-Specific Adoptive T Cell Therapy to Target Viral Reservoirs
The Problem Anti-retroviral therapy (ART) to suppress HIV requires lifelong treatment that can have side effects that create a burden for t...
Gene Drive Research Forum
Goals The Gene Drive Research Forum provides a unique environment for interaction among a broad spectrum of stakeholders for engineered gen...
Combining Epitope-Based Vaccine Design with Informatics-Based Evaluation to Obtain a Universal Influenza Vaccine
The Problem Every year, an estimated 291,000 to 646,000 people worldwide die from seasonal influenza-related respiratory illnesses. Current...
Comprehensive Cellular Vaccine Immune Monitoring Consortium
The Problem The development of a safe and broadly effective vaccine against HIV/AIDS has been elusive and, despite decades of effort, eve...
Biomarkers Consortium – Developing Endpoints for Clinical Trials in Community Acquired Bacterial Pneumonia (CABP) and Acute Skin and Skin Infections (ABSSSI)
The Problem To develop effective treatments for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection...
ACTIV Seminar Series: Post-Acute Sequelae of SARS-CoV-2
Overview COVID patients who experience lingering symptoms for months or weeks after initial recovery are said to have post-acute sequelae o...
GeneConvene Global Collaborative
Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV)

Diseases

Partner With Us